Dr. Lino Teichmann

Medical Clinic III

Medical Faculty, University of Bonn University Hospital of Bonn Sigmund-Freud-Strasse 25 53105 Bonn

lino.teichmann@ukbonn.de

+49 228 28751630

Website

Recent publications

Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial.

22/10/2026 Blood cancer journal

Authors: Steffen Koschmieder, Susanne Isfort, Lino L Teichmann, Philippe Schafhausen, Florian H Heidel, Carl Crodel, Andreas Hochhaus, Martin Griesshammer, Katja Sockel, Philipp J Jost, Denise Walther, Konstanze Döhner, Joachim R Göthert, Markus Radsak, Marinela Augustin, Heiko Becker, Aristoteles Giagounidis, Markus Schaich, Martine Klausmann, Nikolas von Bubnoff, Frank Stegelmann, Maike Kortmann, Michelle Zentis, Julia Frank, Anna Hagemeier, Martin Hellmich, Tim H Brümmendorf
View this publication
Myeloperoxidase and anti-MPO IgG synergistically enhance TLR9-mediated immune activation in ANCA-associated vasculitis.

25/09/2026 Cell reports

Authors: Calvin Krollmann, Maria-Lourdes Saenz, Ruth-Miriam Koerber, Kevin Cieslak, Angela Rösen-Wolff, Peter Brossart, Valentin S Schäfer, Natalio Garbi, Abraham Rutgers, Peter Heeringa, Lino L Teichmann
View this publication
DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy.

05/08/2026 BMC cancer

Authors: Olga Grishina, Claudia Schmoor, Caroline Sellner, Björn Hackanson, Jan-Henrik Mikesch, Iordanis Deligiannis, Felicitas Thol, Martina Crysandt, Christian Junghanss, Volker Runde, Paul La Rosée, Lino Lars Teichmann, Haifa Kathrin Al-Ali, Tim Sauer, Ulrich Germing, Frank Griesinger, Stefan Lukic, Jürgen Krauter, Snjezana Janjetovic, Jan Koch, Peter Staib, Julian Topaly, Maike de Wit, Doris Maria Kraemer, Lorenz Oelschläger, Ulf Schnetzke, Oliver Schmah, Swen Wessendorf, Cyrus Khandanpour, Lukas Kündgen, Monika Schwalenberg, Michael Heuser, Arnold Ganser, Hartmut Döhner, Ralph Wäsch, Michael Lübbert
View this publication

All publications by Dr. Lino Teichmann

Medical Clinic III

Recent publications

Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial.

Myeloperoxidase and anti-MPO IgG synergistically enhance TLR9-mediated immune activation in ANCA-associated vasculitis.

DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy.